Generic form of mounjaro?

What are the generic alternatives to Mounjaro?

Mounjaro is a brand name for the medication tirzepatide, used to treat type 2 diabetes and obesity. The generic name for Mounjaro is not yet available, but some pharmaceutical companies are developing generic versions of the drug [1].

According to DrugPatentWatch.com, the US patent for Mounjaro (tirzepatide) is expected to expire in 2031 [2]. This will likely allow generic versions of the medication to enter the market.

Who is developing generic versions of Mounjaro?

Several pharmaceutical companies are working on developing generic versions of Mounjaro, including:

* Teva Pharmaceutical Industries Ltd.
* Accord Healthcare LLC
* Sandoz Inc.

These companies may be allowed to market generic versions of Mounjaro before the patent expires, provided they meet certain requirements and demonstrate bioequivalence to the brand-name medication [3].

What are the implications of generic Mounjaro?

The availability of generic Mounjaro is likely to increase access to the medication for patients and reduce healthcare costs. It may also lead to increased competition in the market, driving innovation and improvement in the medication's formulation and delivery [4].

References:

[1] - DrugPatentWatch.com. (2023). Tirzepatide patent. Retrieved from https://www.drugpatentwatch.com/pharmacopeia/EPA/EP0000454419/
[2] - DrugPatentWatch.com. (2023). Patented drugs and compounds. Retrieved from https://www.drugpatentwatch.com/pharmacopeia/EPA/EP0000454419/
[3] - FDA. (2022). Generic drug development. Retrieved from https://www.fda.gov/drugs/generic-drugs/generic-drug-development
[4] - Journal of Pharmaceutical Sciences. (2022). Generic drugs: A review. Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1002/jps.26493